ESR11 

Simon Stegemann: ESR-11

Institution: KU Leuven

Nationality: German

simon.stegemann@kuleuven.be

Within the MEDICIS-Promed project, I am part of the Work Package that is developing the required production, mass separation and pre-acceleration accelerator elements to test the direct use of PET 11C ion beams for hadron therapy. At the KU Leuven we have different mass separators operational or under construction. My task is to develop a compact ion-source & mass separator system in order to produce mass separated beams of CO+, CO2+ and CH4+ with high efficiency. In that context, I study different options to produce and mass separate these isotopes at the off-line separator at KU Leuven and at the CERN MEDICIS facility. 

Post no.

ESR 11

Duration

36 months

Work package

WP2, D2.1: Mass separated beams of CO+, CO2+ and CH4+ with high efficiency

Recruiting partner

University of Leuven, Belgium

Objective

Development of mass separation and laser ionization techniques to produce innovative medical radioisotopes

Expected results

MEDICIS-PROMED will train a new generation of 15 entrepreneurial scientists, who will be able to bridge the different disciplines across fundamental research institutions, private companies and hospitals, which is required for the rapid marketing of new types of equipment in companies and drugs used for radiopharmaceuticals in cancer treatments in hospitals. This will be done using radioactive ion beams that have up to now never been used to produce dedicated medical batches for radiopharmaceuticals or to perform hadrontherapy treatments directly with PET imaging 11C ions. This will now become possible with the ongoing construction of CERN-MEDICIS facility to extend the capabilities of the ISOLDE facility. The PhD project deals with the development of mass separation and laser ionization techniques to produce innovative medical radioisotopes. Different options to produce and mass separate the isotopes of interest will be investigated with the local off-line mass separator and laser laboratories at KU Leuven and at the MEDICIS complex currently under construction at CERN.

Enrolment for PhD at

University of Leuven, Belgium

Planned secondment(s)

CNAO, Italy – 10 months – Hadron therapy tests with 13CO/CO2/CH4